On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
For Patients with Chronic Pain…Blame Dad?
A Japanese study suggests that parental bonding style during childhood is associated with the prevalence of chronic pain in adults in the general population and that the association is more robust for paternal bonding than for maternal bonding.
FDA Approves Another PCSK9 Inhibitor
The US Food and Drug Administration last night announced it has approved evolocumab (Repatha/Amgen), an injectable drug for some patients who are unable to get their LDL cholesterol under control. Statins are a cheaper and generally effective treatment, but the new class of drugs is expected to help people who cannot tolerate them, for whom they do not work, and for people with heterozygous familial hypercholesterolemia.
Study: Yoga Effective in Reducing Stress for Inmates
Yoga has shown to improve heart health and benefit patients with rheumatoid arthritis. Even those with breast cancer have gotten in on the action. A new study in Evidence-Based Complementary and Alternative Medicine provides evidence that yoga offers progressive beneficial anti-stress benefits to members of a prison population.
Despite 100 Years of Research, Wound Care is Still an Itch in Need of a Scratch
A recent review in Chronic Wound Care Management and Research suggests that wound pruritus is not well understood and is often poorly treated, despite nearly a century of clinical investigation. Irritations of the skin can be as distressing for patients as pain, the authors noted; yet, there is no established treatment protocol for wound pruritus.
New Glycemic Control Combo Approved for Type 2 Diabetes
The US Food and Drug Administration approved a new glycemic control treatment for type 2 diabetes for adults, a combination product made of empagliflozin (Jardiance/ Boehringer Ingelheim) and metformin hydrochloride. It will be marketed as Synjardy in a joint venture with Eli Lilly.
Hypermobility Conditions Treatment Hampered Due to Lack of Clinical Understanding
Mobility is great. Hypermobility? Less great. In the joints, hypermobility leads to musculoskeletal pain – and often times, lots of it. A recent review in the Journal of Pain Research outlined several of the challenges in treating generalized joint hypermobility (GJH) and found many difficult questions and few easy answers.
FDA Updates HIV Drug Labeling for Pediatric Patients
August 27th 2015The US Food and Drug Administration (FDA) updated labeling for rilpivirine, marketed under the name Edurant, for the treatment of the human immunodeficiency virus (HIV). The changes have been made in the dosage and administration, warnings and precautions, adverse reactions, and clinical information sections.
Internet-based Therapy Potentially Useful for Adolescents with Anxiety Disorders
Recent study results suggest Internet-based cognitive behavioral therapy (ICBT) could be useful for adolescents with anxiety disorders along with standard treatment delivered in child and adolescent psychiatric clinics.
Early Use of DMARDs Linked to Delayed Need for Joint Replacement Surgery
Study results suggest that longer exposure to methotrexate and other disease-modifying anti-rheumatic drugs within the first year of diagnosis is associated with a significantly longer time to joint replacement surgery.
Cognitive Deficits in Multiple Sclerosis Attributed to Brain Regional Disconnect
Patients with multiple sclerosis experience decreased connectivity between brain regions leading to the cognitive changes that are a trademark of the disease, according to research published in Neuropsychology.
Health Experts to White House: "Widen Access to Hepatitis C Medications"
Experts from the Public Health Service and President Obama's Advisory Council on HIV/AIDS have asked the administration in a letter to widen access to new, high-cost medications that successfully treat hepatitis C.
Even Light Drinking Can Increase Alcohol-related Cancer Risk
A new cohort review in BMJ suggests that even light to moderate alcoholic consumption is associated with minimally increased risk of overall cancer. Earlier studies have made the link to increased risk of cancer (particularly colorectal, female breast, oral cavity, pharynx, larynx, liver, and esophagus) for heavy consumption, but the news here is that even amounts less than 30 g/day have potential bearing on cancer risk.